The Biden administration today announced $1 billion in American Rescue Plan Act funding for the Centers for Disease Control and Prevention, states and other jurisdictions to expand genomic sequencing to detect and track COVID-19 variants, which it said now comprise about half of U.S. cases. 

The administration said it will distribute $240 million to jurisdictions in early May and a “second tranche” over several years. 

In addition, the administration said it will invest $400 million from ARPA to create six Centers of Excellence in Genomic Epidemiology with state health departments and academic institutions to research and develop genomic surveillance tools and other innovations; and $300 million to build a National Bioinformatics Infrastructure to share and analyze sequence data across the public health system. 
 

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…